Results 1 to 10 of about 62,685 (235)

The Value of Insulin-like Growth Factor 2 in Urinary Exosomes of Bladder Urothelial Carcinoma

open access: yesXiehe Yixue Zazhi, 2022
Objective  To explore the expression of insulin-like growth factor 2 (IGF2) in urinary exosomes of patients with bladder urothelial carcinoma, and to evaluate its clinical value in the diagnosis of bladder urothelial carcinoma.
YANG Tingkai, WEN Jin, JI Zhigang
doaj   +1 more source

Detection of Canine Urothelial Carcinoma Cells in Urine Using 5-Aminolevulinic Acid

open access: yesAnimals, 2022
This study aimed to establish a method to detect canine urothelial carcinoma cells in urine using 5-aminolevulinic acid (5-ALA) and to evaluate its diagnostic accuracy.
Kenjiro Kaji   +3 more
doaj   +1 more source

CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma

open access: yesFrontiers in Oncology, 2021
IntroductionCircular RNAs (circRNAs) are non-coding RNAs that have the structure of a covalently closed loop. Increasing data have proven that circRNAs can influence the progression and chemotherapy sensitivity of tumors.
Jiancheng Lv   +11 more
doaj   +1 more source

Stromal Lymphoid Response Status in Micropapillary Urothelial Carcinomas Diagnosed in Bladder Transurethral Resections and its Comparison with Conventional Urothelial Carcinomas

open access: yesTürk Patoloji Dergisi, 2021
Objective: Micropapillary urothelial carcinoma is an aggressive variant of urothelial carcinoma. Evidence suggests that the relationship between the tumor and inflammatory cells is important in tumor progression and the treatment response.
Ezgi HACIHASANOĞLU   +3 more
doaj   +1 more source

Prognostic and Diagnostic Significance of Platelet Indices in Patients with Urothelial Carcinoma

open access: yesUro, 2021
Some prognostic markers have been shown to determine the course and survival of Urothelial Cancer. A cross-sectional retrospective study, specifically looking at the role that various indices related to platelets—namely Mean Platelet Volume (MPV ...
Gulshan Kumar Mukhiya   +3 more
doaj   +1 more source

A PD-1 Inhibitor Induces Complete Response of Advanced Bladder Urothelial Carcinoma: A Case Report

open access: yesFrontiers in Oncology, 2021
The prognosis of patients with advanced urothelial carcinoma is dismal. Platinum-based chemotherapy is still the main first-line treatment for advanced urothelial carcinoma, while immunotherapy can be used as a first-line treatment option for people who ...
Jianzheng Wang   +9 more
doaj   +1 more source

CDK6 Immunophenotype Implicates Potential Therapeutic Application of CDK4/6 Inhibitors in Urothelial Carcinoma

open access: yesFrontiers in Oncology, 2022
BackgroundInfiltrating bladder urothelial carcinoma is the most common bladder malignancy with limited therapeutic options and poor prognosis. Identifying new therapeutic targets or strategies has important clinical significance.
Ran Sun   +6 more
doaj   +1 more source

Plasmacytoid urothelial carcinoma of renal pelvis with positive zinc finger E–box–binding homeobox 1: a case report

open access: yesDiagnostic Pathology, 2020
Background The tumor transformation mechanism of a plasmacytoid urothelial carcinoma remains unexplained. We describe the case of a plasmacytoid urothelial carcinoma of the renal pelvis in which the expression of zinc finger E–box–binding homeobox 1 ...
Atsuko Takada-Owada   +8 more
doaj   +1 more source

Testicular metastasis from urothelial carcinoma of the bladder

open access: yesIJU Case Reports, 2022
Introduction Reports of urothelial carcinoma with testicular metastasis are limited and the etiology and prognosis remain unclear. We report a rare case of testicular metastasis derived from bladder urothelial carcinoma.
Eri Fukagawa   +4 more
doaj   +1 more source

Clinicopathological profile of urothelial carcinoma of the bladder: A five-year retrospective study [PDF]

open access: yesRomanian Journal of Medical Practice, 2023
Background and Objectives. Urothelial carcinoma of the bladder is more common than urothelial carcinoma of the upper urinary tract. Carcinoma of the bladder is the tenth most common cancer in the world, with 570,000 new cases and 213,000 deaths annually.
Syifa Ul Izzah, Imam Susilo
doaj   +1 more source

Home - About - Disclaimer - Privacy